DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Guidelines for Preclinical and Clinical Evaluation of Agents Used for the prevention or Treatment of Postmenopausal osteoporosis.
Division of Metabolism and Endocrine Drug Products, Food and Drug Administration. 1994;
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.